Jazz Pharmaceuticals (JAZZ) Gross Profit Growth (5y) (2015 - 2026)
Jazz Pharmaceuticals (JAZZ) Gross Profit Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Jazz Pharmaceuticals | 15.75 Bn | 13.91 Bn | 934.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.50% |
| Dec 31, 2025 | 11.16% |
| Sep 30, 2025 | 12.44% |
| Jun 30, 2025 | 11.88% |
| Mar 31, 2025 | 9.60% |
| Dec 31, 2024 | 11.92% |
| Sep 30, 2024 | 13.50% |
| Jun 30, 2024 | 13.01% |
| Mar 31, 2024 | 11.41% |
| Dec 31, 2023 | 14.98% |
| Sep 30, 2023 | 14.68% |
| Jun 30, 2023 | 13.26% |
| Mar 31, 2023 | 13.43% |
| Dec 31, 2022 | 14.38% |
| Sep 30, 2022 | 16.46% |
| Jun 30, 2022 | 17.51% |
| Mar 31, 2022 | 14.91% |
| Dec 31, 2021 | 15.95% |
| Sep 30, 2021 | 14.81% |
| Jun 30, 2021 | 12.24% |